Germline CDH1 point or small frameshift mutations can be identified in 30–50% of HDGC families, while CDH1 large deletions account for less than 5% of pathogenic variants [47,73]. This evidence concerns the gene CDH1 and CDH1-related diffuse gastric and lobular breast cancer syndrome.